Rapt Therapeutics Stock Story
| RAPT Stock | USD 7.90 0.10 1.25% |
Slightly above 67% of RAPT Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding RAPT Therapeutics suggests that many traders are alarmed. RAPT Therapeutics' investor sentiment overview provides quick insight into current market opportunities from investing in RAPT Therapeutics. The current market sentiment, together with RAPT Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use RAPT Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
RAPT Therapeutics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of RAPT daily returns and investor perception about the current price of RAPT Therapeutics as well as its diversification or hedging effects on your existing portfolios.
RAPT |
Requested story not found. it has been either deleted or moved. View all stories for RAPT Therapeutics.
RAPT Therapeutics Latest Timeline
RAPT Therapeutics is listed for 7.90. About 98.0% of the company shares are owned by institutional investors. The book value of RAPT Therapeutics was at this time reported as 4.27. The company recorded a loss per share of 3.05. RAPT Therapeutics had not issued any dividends in recent years. The entity had 21:1 split on the December 14, 2010.Check out RAPT Therapeutics Hype Analysis, RAPT Therapeutics Correlation and RAPT Therapeutics Performance. For more information on how to buy RAPT Stock please use our How to Invest in RAPT Therapeutics guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Complementary Tools for RAPT Stock analysis
When running RAPT Therapeutics' price analysis, check to measure RAPT Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RAPT Therapeutics is operating at the current time. Most of RAPT Therapeutics' value examination focuses on studying past and present price action to predict the probability of RAPT Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RAPT Therapeutics' price. Additionally, you may evaluate how the addition of RAPT Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |
Is RAPT Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of RAPT Therapeutics. If investors know RAPT will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about RAPT Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.05) | Quarterly Revenue Growth (1.00) | Return On Assets (0.36) | Return On Equity (0.60) |
The market value of RAPT Therapeutics is measured differently than its book value, which is the value of RAPT that is recorded on the company's balance sheet. Investors also form their own opinion of RAPT Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is RAPT Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because RAPT Therapeutics' market value can be influenced by many factors that don't directly affect RAPT Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between RAPT Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if RAPT Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, RAPT Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.